RELIABLE PHARMACEUTICAL RETURNS, LLC: public contracts won without a rival in United States

Updated 17 October 2026 · 2023-10-01 to 2023-10-01 · all of United States · record in the register

RELIABLE PHARMACEUTICAL RETURNS, LLC: public contracts won without a rival in United States: 1 uncontested awards; 3% of its awards; 1 without a competition; 0 single bid.

Assay record ASY-US-0PUVWSL1Q2 · Cite as: Assay Systems, “RELIABLE PHARMACEUTICAL RETURNS, LLC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/reliable-pharmaceutical-returns-llc/

1
1uncontested awards
3%of its awards
1without a competition
0single bid

RELIABLE PHARMACEUTICAL RETURNS, LLC won 1 of its 38 public contract awards in United States without a rival from 2023-10-01 to 2023-10-01, worth $39.8K: 1 without a competition and 0 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Department of the Air Force with 1.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

Department of the Air Force1uncontested1awards$39.8Kvalue

Department of the Air Force gave RELIABLE PHARMACEUTICAL RETURNS, LLC 1 award: 1 without a competition, 0 after a competition with a single bid. First 2023-10-01, latest 2023-10-01.

Latest awards without a rival

DateBuyerHowValueStated reason
2023-10-01Department of the Air Force
FA330021C0006
No competition
NOT AVAILABLE FOR COMPETITION
$39.8KAUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))

Every uncontested award in United States · All countries · RELIABLE PHARMACEUTICAL RETURNS, LLC in the register

Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.